• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鬼臼毒素酯凝胶治疗光化性唇炎:4例报告。

Ingenol mebutate gel treatment for actinic cheilitis: report of four cases.

作者信息

Barrado Solís Nerea, Molés Poveda Paula, Lloret Ruiz César, Pont Sanjuan Virginia, Velasco Pastor Manel, Quecedo Estébanez Esther, Miquel Miquel Javier

机构信息

Department of Dermatology, Arnau de Vilanova Hospital, Valencia, Spain.

出版信息

Dermatol Ther. 2015 Mar-Apr;28(2):79-82. doi: 10.1111/dth.12188. Epub 2014 Dec 29.

DOI:10.1111/dth.12188
PMID:25545762
Abstract

Actinic cheilitis (AC) are premalignant lesions that have an increased risk of malignant transformation. Their treatment, therefore, is essential to prevent carcinogenesis. However, optimal therapy is not well established and different modalities yield variable results. Ingenol mebutate gel has recently been approved by the US Food and Drug Administration for topical treatment of actinic keratosis, with high clearance rates. On the basis of these findings, we report our experience with this drug for the treatment of AC.

摘要

光化性唇炎(AC)是具有恶变风险增加的癌前病变。因此,对其进行治疗对于预防癌变至关重要。然而,最佳治疗方法尚未明确确立,不同的治疗方式产生的效果也各不相同。鬼臼毒素凝胶最近已被美国食品药品监督管理局批准用于光化性角化病的局部治疗,清除率很高。基于这些发现,我们报告了我们使用这种药物治疗AC的经验。

相似文献

1
Ingenol mebutate gel treatment for actinic cheilitis: report of four cases.鬼臼毒素酯凝胶治疗光化性唇炎:4例报告。
Dermatol Ther. 2015 Mar-Apr;28(2):79-82. doi: 10.1111/dth.12188. Epub 2014 Dec 29.
2
Management of actinic cheilitis using ingenol mebutate gel: A report of seven cases.使用鬼臼毒素凝胶治疗光化性唇炎:7例报告。
J Dermatolog Treat. 2017 Mar;28(2):149-151. doi: 10.1080/09546634.2016.1188196. Epub 2016 May 31.
3
Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis.鬼臼毒素丁酯治疗顽固性慢性光化性唇炎。
Dermatology. 2016;232 Suppl 1:1-3. doi: 10.1159/000447386. Epub 2016 Aug 11.
4
Dermoscopy and reflectance confocal microscopy for monitoring the treatment of actinic cheilitis with ingenol mebutate gel: Report of three cases.利用二氯乙酸凝胶治疗光化性唇炎的皮肤镜和反射共聚焦显微镜监测:三例报告。
Dermatol Ther. 2018 Jul;31(4):e12613. doi: 10.1111/dth.12613. Epub 2018 Apr 24.
5
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.0.025%和0.05%鬼臼毒素丁酯凝胶治疗光化性角化病的随机、双盲、双模拟、赋形剂对照研究
J Am Acad Dermatol. 2009 Jun;60(6):934-43. doi: 10.1016/j.jaad.2009.01.008.
6
Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.用氨基酮戊酸光动力疗法(ALA-PDT)或0.015%鬼臼毒素凝胶治疗面部光化性角化病,以及是否在ALA-PDT治疗之前进行治疗。
J Drugs Dermatol. 2014 Nov;13(11):1353-6.
7
Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes.咪喹莫特乳膏治疗光化性角化病:生活质量、治疗满意度和临床结局之间的联系。
J Am Acad Dermatol. 2015 May;72(5):816-21. doi: 10.1016/j.jaad.2015.01.036. Epub 2015 Mar 11.
8
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.PEP005(鬼臼毒素)凝胶,一种治疗光化性角化病的新型药物:一项随机、双盲、赋形剂对照、多中心IIa期研究的结果。
Australas J Dermatol. 2009 Feb;50(1):16-22. doi: 10.1111/j.1440-0960.2008.00497.x.
9
Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.在社区皮肤科诊所中,咪喹莫特凝胶用于治疗光化性角化病患者。
J Drugs Dermatol. 2014 Mar;13(3):269-73.
10
Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.长期随访研究表没食子儿茶素没食子酸酯凝胶治疗光化性角化病。
JAMA Dermatol. 2013 Jun;149(6):666-70. doi: 10.1001/jamadermatol.2013.2766.

引用本文的文献

1
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis.三氯乙酸作为光化性唇炎的局部治疗方法
OTO Open. 2025 May 23;9(2):e70132. doi: 10.1002/oto2.70132. eCollection 2025 Apr-Jun.
2
Trends in cutaneous squamous cell carcinoma on the lip incidence and mortality in the United States, 2000-2019.2000 - 2019年美国唇部皮肤鳞状细胞癌的发病率和死亡率趋势
Front Oncol. 2023 Apr 17;13:1111907. doi: 10.3389/fonc.2023.1111907. eCollection 2023.
3
Daylight photodynamic therapy for the management of actinic cheilitis.日光光动力疗法治疗光化性唇炎。
Arch Dermatol Res. 2020 Dec;312(10):731-737. doi: 10.1007/s00403-020-02069-y. Epub 2020 Apr 7.
4
Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis.ingenol mebutate外用凝胶:光化性角化病以外临床应用的现状报告
J Clin Aesthet Dermatol. 2016 Nov;9(11 Suppl 1):S3-S11.